Yıl: 2018 Cilt: 52 Sayı: 2 Sayfa Aralığı: 124 - 128 Metin Dili: İngilizce DOI: 10.14744/SEMB.2017.58076 İndeks Tarihi: 20-10-2018

Extracorporeal Shock Wave Therapy in Dupuytren’s Disease

Öz:
Objectives: We investigated the use of extracorporeal shock wave therapy (ESWT) in patients with Dupuytren’s Disease (DD) palmar nodules in an attempt to reduce the contracture, alleviate the pain (if any), increase the range of motion and quality of life, and delay a probable surgery in the long term. Methods: Patients with DD who presented to our hand surgery clinic and fulfilled the inclusion criteria were enrolled. The treatment was performed by the same physician using the ESWT device once a week for six weeks. The patients were evaluated with the VAS score, Quick-DASH questionnaire, and MAYO wrist score, and their grip strength was measured using a Jamar dynamometer. Results: The mean age of the 23 patients included in the study was 51 years. There was a significant improvement in the second measurement of VAS and DASH scores compared with the preoperative values. The increase in the second and final follow-up measurements of the MAYO score and grip strength results compared with the preoperative values was found significant. The table-top test results turned negative in 16 patients. Conclusion: We can suggest that ESWT in the early term can be preferred over costly injections and surgical intervention options as it increases the quality of life and delays the recurrence of contractures.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Knobloch K, Vogt PM. High-energy focussed extracorporeal shockwave therapy reduces pain in plantar fibromatosis (Ledderhose's disease). BMC Res Notes 2012;5:542.
  • Palmieri A, Imbimbo C, Longo N, Fusco F, Verze P, Mangiapia F, et al. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. Eur Urol 2009;56:363–9.
  • Srirangam SJ, Manikandan R, Hussain J, Collins GN, O'Reilly PH. Long-term results of extracorporeal shockwave therapy for Peyronie's disease. J Endourol 2006;20:880–4.
  • Andrade E, Cortez I, Claro J, Pompeu E, Leite K, Paranhos M, et al. Preliminary findings from a new animal model for Peyronie's disease involving extracorporeal shock waves. BJU Int 2009;103:1104–6.
  • SooHoo NF, McDonald AP, Seiler JG 3rd, McGillivary GR. Evaluation of the construct validity of the DASH questionnaire by correlation to the SF-36. J Hand Surg Am 2002;27:537–41.
  • McCarthy DM. The long-term results of enzymic fasciotomy. J Hand Surg Br 1992;178:356.
  • Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up. J Hand Surg Am 2010;35:534–9, 539.
  • Chen NC, Srinivasan RC, Shauver MJ, Chung KC. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture. Hand (N Y) 2011;6:250–5.
  • Werker PM, Pess GM, van Rijssen AL, Denkler K. Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: the importance of clear definitions. J Hand Surg Am 2012;37:2095–105.
  • Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg Am 2000;25:629–36.
  • Luck JV. Dupuytren's contracture; a new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am 1959;41-A:635–64.
  • Dominguez-Malagon HR, Alfeiran-Ruiz A, Chavarria-Xicotencatl P, Duran-Hernandez MS. Clinical and cellular effects of colchicine in fibromatosis. Cancer 1992;69:2478–83.
  • Knobloch K, Kuehn M, Vogt PM. Focused extracorporeal shockwave therapy in Dupuytren's disease--a hypothesis. Med Hypotheses 2011;76:635–7.
  • Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg Am 2002;27:788–98.
  • Bansal V, Naidu SH. Dupuytren’s disease. Curr Opin Orthop 2005;16:236–9.
  • Short WH, Watson HK. Prediction of the spiral nerve in Dupuytren's contracture. J Hand Surg Am 1982;7:84–6.
  • Umlas ME, Bischoff RJ, Gelberman RH. Predictors of neurovascular displacement in hands with Dupuytren's contracture. J Hand Surg Br 1994;19:664–6.
  • McGrouther DA. Dupuytren's contracture. In: Green DP, Hotchkiss RN, Pederson WC, editors. Operative Hand Surgery. 4th ed. New York: Churchill Livingstone; 1999. p. 563–91.
  • Hu FZ, Nystrom A, Ahmed A, Palmquist M, Dopico R, Mossberg I, et al. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin Genet 2005;68:424–9
APA Aykut S, Aydın C, ÖZTÜRK K, ARSLANOĞLU F, kilinc c (2018). Extracorporeal Shock Wave Therapy in Dupuytren’s Disease. , 124 - 128. 10.14744/SEMB.2017.58076
Chicago Aykut Serkan,Aydın Canan,ÖZTÜRK Kahraman,ARSLANOĞLU FATİH,kilinc cem yalin Extracorporeal Shock Wave Therapy in Dupuytren’s Disease. (2018): 124 - 128. 10.14744/SEMB.2017.58076
MLA Aykut Serkan,Aydın Canan,ÖZTÜRK Kahraman,ARSLANOĞLU FATİH,kilinc cem yalin Extracorporeal Shock Wave Therapy in Dupuytren’s Disease. , 2018, ss.124 - 128. 10.14744/SEMB.2017.58076
AMA Aykut S,Aydın C,ÖZTÜRK K,ARSLANOĞLU F,kilinc c Extracorporeal Shock Wave Therapy in Dupuytren’s Disease. . 2018; 124 - 128. 10.14744/SEMB.2017.58076
Vancouver Aykut S,Aydın C,ÖZTÜRK K,ARSLANOĞLU F,kilinc c Extracorporeal Shock Wave Therapy in Dupuytren’s Disease. . 2018; 124 - 128. 10.14744/SEMB.2017.58076
IEEE Aykut S,Aydın C,ÖZTÜRK K,ARSLANOĞLU F,kilinc c "Extracorporeal Shock Wave Therapy in Dupuytren’s Disease." , ss.124 - 128, 2018. 10.14744/SEMB.2017.58076
ISNAD Aykut, Serkan vd. "Extracorporeal Shock Wave Therapy in Dupuytren’s Disease". (2018), 124-128. https://doi.org/10.14744/SEMB.2017.58076
APA Aykut S, Aydın C, ÖZTÜRK K, ARSLANOĞLU F, kilinc c (2018). Extracorporeal Shock Wave Therapy in Dupuytren’s Disease. Şişli Etfal Hastanesi Tıp Bülteni, 52(2), 124 - 128. 10.14744/SEMB.2017.58076
Chicago Aykut Serkan,Aydın Canan,ÖZTÜRK Kahraman,ARSLANOĞLU FATİH,kilinc cem yalin Extracorporeal Shock Wave Therapy in Dupuytren’s Disease. Şişli Etfal Hastanesi Tıp Bülteni 52, no.2 (2018): 124 - 128. 10.14744/SEMB.2017.58076
MLA Aykut Serkan,Aydın Canan,ÖZTÜRK Kahraman,ARSLANOĞLU FATİH,kilinc cem yalin Extracorporeal Shock Wave Therapy in Dupuytren’s Disease. Şişli Etfal Hastanesi Tıp Bülteni, vol.52, no.2, 2018, ss.124 - 128. 10.14744/SEMB.2017.58076
AMA Aykut S,Aydın C,ÖZTÜRK K,ARSLANOĞLU F,kilinc c Extracorporeal Shock Wave Therapy in Dupuytren’s Disease. Şişli Etfal Hastanesi Tıp Bülteni. 2018; 52(2): 124 - 128. 10.14744/SEMB.2017.58076
Vancouver Aykut S,Aydın C,ÖZTÜRK K,ARSLANOĞLU F,kilinc c Extracorporeal Shock Wave Therapy in Dupuytren’s Disease. Şişli Etfal Hastanesi Tıp Bülteni. 2018; 52(2): 124 - 128. 10.14744/SEMB.2017.58076
IEEE Aykut S,Aydın C,ÖZTÜRK K,ARSLANOĞLU F,kilinc c "Extracorporeal Shock Wave Therapy in Dupuytren’s Disease." Şişli Etfal Hastanesi Tıp Bülteni, 52, ss.124 - 128, 2018. 10.14744/SEMB.2017.58076
ISNAD Aykut, Serkan vd. "Extracorporeal Shock Wave Therapy in Dupuytren’s Disease". Şişli Etfal Hastanesi Tıp Bülteni 52/2 (2018), 124-128. https://doi.org/10.14744/SEMB.2017.58076